Phenotype
|
Fish
|
Conditions
|
Figures
|
heart dlg1a expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
heart heart looping process quality, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart rangrf expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
anterior lateral plate mesoderm nkx2.5 expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart cryabb expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 3,
Fig. 4
from Gou et al., 2020
|
heart nppa expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
whole organism rangrf expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 1
from Gou et al., 2020
|
heart calm3a expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
heart scn1ba expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
atrioventricular canal endocardium notch1b expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
cardiac ventricle myh7 expression spatial pattern, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal myocardium vcana expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart heart contraction decreased process quality, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
heart heart contraction decreased rate, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
heart heart contraction decreased process quality, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 2,
Fig. 6
from Gou et al., 2020
|
heart hspb2 expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 3,
Fig. 4
from Gou et al., 2020
|
pericardium edematous, exacerbated
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
heart myl7 expression spatial pattern, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart ank3a expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
heart cryabb expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
heart rangrf expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 1,
Fig. 4
from Gou et al., 2020
|
heart nppa expression increased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
heart nppa expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 4
from Gou et al., 2020
|
heart nppb expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 4
from Gou et al., 2020
|
pericardium edematous, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
anterior lateral plate mesoderm gata4 expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart nppb expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
ventricular myocardium increased thickness, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
ventricular myocardium increased thickness, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
heart hspb2 expression decreased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
anterior lateral plate mesoderm hand2 expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal endocardium has2 expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
whole organism decreased weight, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
heart actn2a expression increased amount, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
atrium myh6 expression spatial pattern, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal myocardium bmp4 expression decreased distribution, abnormal
|
rangrfhzu101/hzu101 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart heart looping process quality, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
anterior lateral plate mesoderm nkx2.5 expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
whole organism rangrf expression decreased amount, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 1
from Gou et al., 2020
|
atrioventricular canal endocardium notch1b expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart heart contraction decreased process quality, abnormal
|
rangrfhzu102/hzu102 (AB)
|
chemical treatment by environment: isoprenaline
|
Fig. 4
from Gou et al., 2020
|
cardiac ventricle myh7 expression spatial pattern, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal myocardium vcana expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart heart contraction decreased rate, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 6
from Gou et al., 2020
|
heart heart contraction decreased process quality, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 2,
Fig. 6
from Gou et al., 2020
|
heart myl7 expression spatial pattern, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart nppa expression increased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
heart rangrf expression decreased amount, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 1
from Gou et al., 2020
|
ventricular myocardium increased thickness, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
anterior lateral plate mesoderm gata4 expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
anterior lateral plate mesoderm hand2 expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
whole organism decreased weight, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 2
from Gou et al., 2020
|
atrium myh6 expression spatial pattern, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal myocardium bmp4 expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
atrioventricular canal endocardium has2 expression decreased distribution, abnormal
|
rangrfhzu102/hzu102 (AB)
|
standard conditions
|
Fig. 7
from Gou et al., 2020
|
heart heart looping process quality, abnormal
|
rangrfhzu101/hzu101; twu34Tg (AB)
|
standard conditions
|
Fig. S4
from Gou et al., 2020
|
heart EGFP expression spatial pattern, abnormal
|
rangrfhzu101/hzu101; twu34Tg (AB)
|
standard conditions
|
Fig. S4
from Gou et al., 2020
|